Not applicableLooking for participantsNCT05235464What this trial is testingHigh Protein Diet and AtherosclerosisWho this might be right forAtherosclerosis University of Missouri-Columbia 24
Not applicableLooking for participantsNCT07121010What this trial is testingHow Animal and Plant Protein Shakes Change the Body's Nutrient and Health ResponsesWho this might be right forCardiometabolic Health University of Pittsburgh 20
Testing effectiveness (Phase 2)Study completedNCT01467986What this trial is testingMultimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk NeuroblastomaWho this might be right forNeuroblastoma Recurrent University of Regensburg 130
Early research (Phase 1)Study completedNCT01353625What this trial is testingStudy to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.Who this might be right forGlioblastoma MultiformeSquamous Cell Carcinoma of Head and NeckProstate Cancer+3 more Celgene 118
Not applicableEnded earlyNCT03946774What this trial is testingDietary Protein and Monocyte/Macrophage Mammalian Target of Rapamycin (mTOR) SignalingWho this might be right forDietary Protein Washington University School of Medicine 21
Early research (Phase 1)Study completedNCT01854606What this trial is testingSafety and Efficacy of AEB071 and EVEROLIMUS in Patients With CD79-mutant or ABC Subtype Diffuse Large B-Cell LymphomaWho this might be right forCD79 Mutant or ABC-subtype Diffuse Large B-Cell Lymphoma Novartis Pharmaceuticals 31
Early research (Phase 1)Study completedNCT00973076What this trial is testingStudy to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055Who this might be right forCancerSolid TumorsAdvanced Solid Malignancies AstraZeneca 19
Early research (Phase 1)WithdrawnNCT01194193What this trial is testingPreliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced TumoursWho this might be right forCancerAdvanced Solid TumoursLymphomas AstraZeneca 63
Not applicableLooking for participantsNCT05233722What this trial is testingMTOR as Mediator of Insulin Sensitivity StudyWho this might be right forInsulin Sensitivity University of Copenhagen 10
Not applicableUnknownNCT04112537What this trial is testingDermatologic Patterns of Tuberous Sclerosis Patients and Somatic Mutation RelationshipWho this might be right forTuberous Sclerosis Complex University Hospital, Montpellier 90
Early research (Phase 1)Study completedNCT00962507What this trial is testingPanobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaWho this might be right forLymphomaMultiple Myeloma and Plasma Cell Neoplasm City of Hope Medical Center 11
Early research (Phase 1)Study completedNCT02238496What this trial is testingPerifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant GliomasWho this might be right forBrain Tumor, RecurrentGlioblastomaAnaplastic Astrocytoma+2 more Andrew B Lassman, MD 10
Testing effectiveness (Phase 2)Study completedNCT00353301What this trial is testingErlotinib and Sirolimus for the Treatment of Metastatic Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma University of Colorado, Denver 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT06385496What this trial is testingTesting MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With mTOR Genetic Changes (MATCH - Subprotocol L)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT02596828What this trial is testingProspective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade PineoblastomaWho this might be right forPineoblastoma University of Regensburg 4
Testing effectiveness (Phase 2)Study completedNCT01177397What this trial is testingStudy to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple MyelomaWho this might be right forMultiple MyelomaDiffuse Large B-Cell LymphomaGlioblastoma Multiforme+4 more Celgene 226
Early research (Phase 1)Study completedNCT00999882What this trial is testingSafety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer PatientsWho this might be right forCancerAdvanced Hepatocellular Carcinoma AstraZeneca 26